Keyphrases
Antitumor Effect
100%
Bladder Cancer Cell Lines
12%
Bladder Cancer Cells
100%
Cancer Therapy
12%
Caspase-dependent Apoptosis
25%
CCK-8 Assay
12%
Cell Cycle Arrest
12%
Cell Cycle Progression
12%
Cisplatin
100%
Cisplatin Resistance
50%
Clonogenic Assay
12%
Combination Index
12%
Combination Therapy
25%
Dose-ranging
12%
Dose-response Study
12%
Dual Inhibitor
12%
Escalating Dose
12%
Human Bladder Cancer Cells
25%
IC50
12%
Mammalian Target of Rapamycin (mTOR)
25%
MEK-ERK Pathway
12%
NVP-BEZ235
100%
Pathway Activation
12%
PI3K-AKT-mTOR Pathway
25%
PI3K-mTOR Inhibitors
100%
Poor Prognosis
12%
Prototypic
12%
Survival Pathways
25%
Synergistic Antitumor Effect
12%
Synergistic Effect
12%
Synergistic Interaction
25%
Synergy Analysis
12%
Three Dimensional Model
12%
Three-dimensional (3D)
12%
Pharmacology, Toxicology and Pharmaceutical Science
Bladder Cancer
100%
Caspase
18%
Cholecystokinin Octapeptide
9%
Cisplatin
100%
Combination Therapy
18%
Dactolisib
100%
Dose-Response Study
9%
IC50
9%
Malignant Neoplasm
9%
Mammalian Target of Rapamycin Inhibitor
100%
Synergism
18%